Zacks Research upgraded shares of Varex Imaging (NASDAQ:VREX – Free Report) from a hold rating to a strong-buy rating in a report released on Monday,Zacks.com reports.
VREX has been the topic of a number of other reports. B. Riley Financial reiterated a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Wall Street Zen upgraded shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 28th. Jefferies Financial Group reissued a “hold” rating and set a $14.50 price target on shares of Varex Imaging in a research report on Monday, February 2nd. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a report on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Varex Imaging currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.17.
Read Our Latest Analysis on Varex Imaging
Varex Imaging Trading Up 2.8%
Varex Imaging (NASDAQ:VREX – Get Free Report) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. The firm had revenue of $209.60 million for the quarter, compared to the consensus estimate of $207.83 million. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. Equities analysts forecast that Varex Imaging will post 0.53 EPS for the current fiscal year.
Insider Activity
In other news, Director Jay K. Kunkel sold 4,510 shares of Varex Imaging stock in a transaction on Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the sale, the director directly owned 23,450 shares in the company, valued at approximately $261,233. The trade was a 16.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 4.60% of the company’s stock.
Hedge Funds Weigh In On Varex Imaging
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Empowered Funds LLC increased its holdings in shares of Varex Imaging by 7.3% in the first quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock valued at $2,078,000 after purchasing an additional 12,151 shares during the period. Jane Street Group LLC raised its position in Varex Imaging by 17.9% during the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock worth $1,849,000 after buying an additional 24,160 shares during the last quarter. Rhumbline Advisers lifted its stake in Varex Imaging by 4.6% during the 2nd quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock valued at $536,000 after acquiring an additional 2,694 shares during the period. Hsbc Holdings PLC boosted its holdings in shares of Varex Imaging by 19.7% in the 2nd quarter. Hsbc Holdings PLC now owns 47,525 shares of the company’s stock valued at $408,000 after acquiring an additional 7,825 shares during the last quarter. Finally, Quantbot Technologies LP increased its stake in shares of Varex Imaging by 25.1% in the second quarter. Quantbot Technologies LP now owns 47,292 shares of the company’s stock worth $410,000 after acquiring an additional 9,476 shares during the period.
Varex Imaging Company Profile
Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.
The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.
Featured Articles
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
